US 11365250
Compositions and methods for cancer therapy
granted A61KA61K2039/505A61K38/177
Quick answer
US patent 11365250 (Compositions and methods for cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K38/177, A61P, A61P25/00